SG Americas Securities LLC Has $2.18 Million Position in Teleflex Incorporated $TFX

SG Americas Securities LLC grew its holdings in Teleflex Incorporated (NYSE:TFX) by 123.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,189 shares of the medical technology company’s stock after buying an additional 10,052 shares during the quarter. SG Americas Securities LLC’s holdings in Teleflex were worth $2,176,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in TFX. Banque Cantonale Vaudoise lifted its position in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after buying an additional 113 shares in the last quarter. V Square Quantitative Management LLC acquired a new position in shares of Teleflex during the fourth quarter valued at $37,000. UMB Bank n.a. lifted its stake in shares of Teleflex by 57.1% during the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 113 shares during the period. Sound Income Strategies LLC acquired a new position in shares of Teleflex during the fourth quarter valued at $45,000. Finally, Kestra Advisory Services LLC bought a new position in Teleflex in the fourth quarter valued at about $45,000. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

Shares of TFX stock opened at $129.89 on Thursday. Teleflex Incorporated has a 12 month low of $100.18 and a 12 month high of $139.67. The company has a quick ratio of 2.03, a current ratio of 2.55 and a debt-to-equity ratio of 0.82. The company’s fifty day simple moving average is $129.85 and its 200-day simple moving average is $119.63. The firm has a market cap of $5.75 billion, a PE ratio of -5.70, a P/E/G ratio of 0.94 and a beta of 0.82.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company’s revenue for the quarter was up 32.3% compared to the same quarter last year. During the same quarter last year, the company posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts expect that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. Teleflex’s payout ratio is presently -5.96%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on TFX shares. Raymond James Financial reissued an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Mizuho set a $140.00 price target on shares of Teleflex in a research report on Friday, May 8th. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price for the company in a report on Monday, April 13th. Wells Fargo & Company upped their target price on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Finally, Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $140.00 to $160.00 in a research report on Monday, June 8th. Four analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $146.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.